Compare SXT & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SXT | NOVT |
|---|---|---|
| Founded | 1882 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Industrial Machinery/Components |
| Sector | Industrials | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.7B |
| IPO Year | 1994 | 1999 |
| Metric | SXT | NOVT |
|---|---|---|
| Price | $113.48 | $155.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $121.00 | ★ $144.00 |
| AVG Volume (30 Days) | 373.4K | ★ 440.7K |
| Earning Date | 04-24-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.36% | N/A |
| EPS Growth | ★ 7.48 | N/A |
| EPS | ★ 1.04 | 0.51 |
| Revenue | ★ $1,396,499,000.00 | $521,290,000.00 |
| Revenue This Year | $8.99 | $8.61 |
| Revenue Next Year | $9.45 | $6.57 |
| P/E Ratio | ★ $107.88 | $305.06 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $82.60 | $98.27 |
| 52 Week High | $129.35 | $171.85 |
| Indicator | SXT | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 47.76 | 50.64 |
| Support Level | $110.17 | $147.12 |
| Resistance Level | $118.67 | $168.71 |
| Average True Range (ATR) | 3.57 | 8.62 |
| MACD | -0.75 | -2.02 |
| Stochastic Oscillator | 21.38 | 26.02 |
Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are: Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.